Teligent - 10 Year Stock Price History | TLGT
Historical daily share price chart and data for Teligent since 2011 adjusted for splits and dividends. The latest closing stock price for Teligent as of December 17, 2021 is 0.03.
- The all-time high Teligent stock closing price was 115.20 on February 27, 2015.
- The Teligent 52-week high stock price is 0.00, which is -100% above the current share price.
- The Teligent 52-week low stock price is 0.00, which is 100% below the current share price.
- The average Teligent stock price for the last 52 weeks is 0.00.
| Teligent Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2021 | 0.5216 | 0.7373 | 1.3600 | 0.0280 | 0.0290 | -96.13% |
| 2020 | 2.4799 | 4.2000 | 5.6000 | 0.4790 | 0.7500 | -82.39% |
| 2019 | 9.2654 | 13.2000 | 18.7000 | 4.0030 | 4.2590 | -68.91% |
| 2018 | 32.3679 | 38.5000 | 44.6000 | 11.7000 | 13.7000 | -62.26% |
| 2017 | 69.5486 | 70.5000 | 94.1000 | 29.6000 | 36.3000 | -45.08% |
| 2016 | 67.6310 | 88.1000 | 88.1000 | 46.0000 | 66.1000 | -25.73% |
| 2015 | 80.2341 | 90.7000 | 115.2000 | 50.3000 | 89.0000 | 1.14% |
| 2014 | 62.5931 | 29.6000 | 110.0000 | 29.6000 | 88.0000 | 188.52% |
| 2013 | 17.8512 | 10.4000 | 32.9000 | 10.2000 | 30.5000 | 193.27% |
| 2012 | 11.1009 | 11.1000 | 13.4000 | 9.4000 | 10.4000 | -9.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |